Business
Fresenius Medical Care AG : Release of a capital market information
Fresenius Medical Care AG : Release of a capital market
About this update from Fresenius Medical Care Ag
[{"type":"text","content":"\n\n\nEQS Post-admission Duties announcement: Fresenius Medical Care AG \n\n\n / Disclosure pursuant to Art. 5 para. 1 lit. a) of Regulation (EU) No 596/2014 and Art. 2 pa-ra. 1 of Delegated Regulation (EU) 2016/1052\n\n\n\n\n\nFresenius Medical Care AG : Release of a capital market information \n\n\n\n\n\n\n28.05.2026 / 08:04 CET/CEST\n\n\nDissemination of a Post-admission Duties announcement transmitted by EQS News - a service of EQS Group.\n\nThe issuer is solely responsible for the content of this announcement.Bad Homburg v.d. Höhe, May 28, 2026Disclosure pursuant to Art. 5 para. 1 lit. a) of Regulation (EU) No 596/2014 and Art. 2 para. 1 of Delegated Regulation (EU) 2016/1052\n\nFresenius Medical Care AG (\"FME\") disclosed on May 26, 2026, to conduct the next share buyback program. The program is scheduled to commence on May 28, 2026, and to be completed within 12 months by May 27, 2027 (inclusive). Up to 29,341,344 shares (ISIN DE0005785802, \"FME-Shares\") may be repurchased on the stock exchange or via a multilateral trading facility within the meaning of Section 2 para. 6 of the German Stock Exchange Act (Börsengesetz) for a total purchase price of up to EUR 1 billion (not including ancillary acquisition costs). The purchase of FME-Shares and the maximum number of FME-Shares to be acquired are based on the authorization granted by the General Meeting on May 21, 2026 (\"Authorization\").\n\nThe repurchased FME-Shares are predominantly to be cancelled and the share capital to be reduced accordingly. To a significantly lesser extent, the repurchased FME-Shares may be used for allocations under incentive-based compensation plans.\n\nThe buyback shall be made in tranches. Under the first tranche, FME-Shares shall be acquired for a total amount of up to EUR 600,000,000 (not including ancillary acquisition costs) over a period ending on December 15, 2026 (inclusive) under the following conditions.\n\nThe buyback shall be carried out in accordance with the safe-harbor-provisions of Art. 5 of Regulation (EU) No 596/2014 in conjunction with the provisions of Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 supplementing Regulation (EU) No 596/2014 with regulatory technical standards on the conditions applicable to buyback programs and stabilization measures (\"Delegated Regulation (EU) 2016/1052...